UnknownPhase 2NCT04588818
Adalimumab Plus Methotrexate for the Treatment of Pediatric Uveitis
Studying Infectious panuveitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sun Yat-sen University
- Principal Investigator
- Dan Liang, MDZhongshan Ophthalmic Center, Sun Yat-sen University
- Intervention
- Adalimumab plus Methotrexate(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 2-16 years · All sexes
- Timeline
- 2020 – 2023
Study locations (1)
- Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04588818 on ClinicalTrials.gov